Instant Insight
30-Second Take
- President Donald Trump has issued several executive orders aimed at reversing key health care policies implemented by his predecessor, Joe Biden.
- These orders target drug pricing, the Affordable Care Act, and Medicaid, but will have little immediate impact without further regulatory actions.
- The moves are seen as a signal of Trump’s intention to dismantle Biden-era health care reforms.
+ Dive Deeper
Quick Brief
2-Minute Digest
Essential Context
President Trump’s early executive orders on health care signify his intent to undo several of the health care initiatives introduced by the Biden administration. These orders, issued shortly after Trump’s return to office, include the rescission of directives aimed at lowering drug costs and expanding coverage under the Affordable Care Act and Medicaid.
Core Players
- Donald Trump – President of the United States
- Joe Biden – Former President of the United States
- Larry Levitt – Executive vice president for health policy at KFF
- Joseph Antos – Senior fellow at the American Enterprise Institute
- Omar Gonzalez-Pagan – Senior counsel and health care strategist at Lambda Legal
Key Numbers
- 79 million – Number of people covered by Medicaid and the Children’s Health Insurance Program.
- $2 – Proposed flat copay for some generic drugs in Medicare under Biden’s plan.
- January 20, 2025 – Date Trump issued his executive orders on health care.
+ Full Analysis
Full Depth
Complete Coverage
The Catalyst
President Trump’s decision to issue a flurry of executive orders on his first day back in office marks a significant shift in health care policy. These orders target several key areas, including drug pricing and public insurance programs.
“Everyone is looking for signals on what Trump might do on a host of health issues. On the early EOs, Trump doesn’t show his cards,” said Larry Levitt, executive vice president for health policy at KFF.
Inside Forces
The Trump administration has rescinded directives that promoted lowering drug costs and expanding coverage under the Affordable Care Act and Medicaid. For instance, Trump ended a pilot program that aimed to set a flat $2 copay for some generic drugs in Medicare and another that encouraged states to negotiate better prices for expensive cell and gene therapies.
These moves suggest that Trump may do less on drug pricing this term or even roll back drug price negotiation in Medicare.
Power Dynamics
The relationship between the Trump administration and health care stakeholders is complex. Trump’s actions have been met with criticism from Democrats and concern from patient advocates. “Trump is again proving that he lied to the American people and doesn’t care about lowering costs — only what’s best for himself and his ultra-rich friends,” said Alex Floyd, a spokesman for the Democratic National Committee.
However, some conservative policy groups see opportunities in Trump’s approach. Chris Pope, a senior fellow at the Manhattan Institute, noted that Medicaid has grown significantly and may be a focus for reforms.
Outside Impact
The broader implications of Trump’s executive orders are far-reaching. They could lead to an increase in the number of uninsured Americans and weaken safety net protections for low-income people. Additionally, Trump’s orders on gender identity have intensified concerns within the LGBTQ+ community.
“The administration has forecast that it will fail to protect and will seek to discriminate against transgender people and anyone else it considers an ‘other,’” said Omar Gonzalez-Pagan, senior counsel and health care strategist at Lambda Legal.
Future Forces
Looking ahead, the Trump administration’s health care policies are likely to face significant scrutiny and potential challenges. Republicans are working on budget proposals that could lead to large cuts in Medicaid funding. Sarah Lueck of the Center on Budget and Policy Priorities highlighted that these cuts could be part of broader budget legislation.
Key areas to watch include potential changes to antitrust enforcement, labor regulations, and the coverage of anti-obesity medications through Medicare and Medicaid.
Data Points
- January 20, 2025 – Date Trump issued his executive orders on health care.
- 78 – Number of Biden executive orders rescinded by Trump on his first day.
- 79 million – Number of people covered by Medicaid and the Children’s Health Insurance Program.
- $2 – Proposed flat copay for some generic drugs in Medicare under Biden’s plan.
The early executive orders from the Trump administration set the stage for significant changes in the U.S. health care system. As these policies unfold, they will likely impact millions of Americans, particularly those relying on public insurance programs.
